# Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants

> **NCT00228319** · PHASE1,PHASE2 · COMPLETED · sponsor: **Jeanne Drisko, MD, CNS, FACN** · enrollment: 27 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Oral Ascorbic Acid
- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin
- **DRUG:** Sodium Ascorbate
- **DIETARY_SUPPLEMENT:** Oral Mixed natural Carotenoids with Vitamin A
- **DIETARY_SUPPLEMENT:** Vitamin E

## Key facts

- **NCT ID:** NCT00228319
- **Lead sponsor:** Jeanne Drisko, MD, CNS, FACN
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2018-06-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00228319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00228319, "Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00228319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*